The Impact of Antibiotic-impregnated Catheters on Shunt Infection in Children and Neonates

Overview

Journal Childs Nerv Syst

Specialty Pediatrics

Date 2007 Oct 27

PMID 17962953

Citations 22

Authors

Caroline Hayhurst

Richard Cooke

Dawn Williams

Jothy Kandasamy

Donncha F OBrien

Conor L Mallucci

Affiliations

Soon will be listed here.

Abstract

Introduction: Infection remains a significant problem with cerebrospinal fluid (CSF) diversion procedures. Antibiotic-impregnated shunt catheters (AIS) have been introduced to prevent infection, mainly in the early post-operative period when most infections occur. We evaluate the impact on infection rates in children following the introduction of catheters impregnated with rifampicin and clindamycin.

Materials And Methods: The study was a retrospective analysis of all paediatric shunt procedures undertaken after the introduction of AIS systems in 2003. All procedures where a complete AIS system was implanted were included. For the purpose of analysis, shunt procedures were classified as de novo (group 1), clean revision (group 2) and following external ventricular drainage with either sterile CSF (group 3) or infected CSF (group 4). Results were compared to a historical cohort of shunt procedures undertaken before the introduction of AIS catheters.

Results: A total of 214 AIS were implanted in 150 children between October 2003 and December 2006. There were 4 infections in group 1 (8.5%), 6 infections in group 2 (5.3%) and 11 infections in groups 3 and 4 (20%). The historical control group comprised 77 shunts in 65 children. The infection rate in neonatal de novo shunts reduced from 27 to 10.4% following the introduction of AIS catheters.

Conclusions: AIS catheters can reduce the number of shunt infections seen in clinical practice in certain subgroups. This has had a significant impact on the neonatal hydrocephalic population. The high risk of shunt infection after a period of external ventricular drainage raises the issue of emergence of bacterial resistance.

Citing Articles

Infection rates during eras of intrathecal antibiotic use followed by antibiotic-impregnated catheter use in prevention of cerebrospinal fluid shunt infection.

Simon T, Rezvan P, Coffin S, Hall M, Hauptman J, Kronman M J Neurosurg Pediatr. 2024; 34(4):357-364.

PMID: 39029119 PMC: 11444882. DOI: 10.3171/2024.5.PEDS23372.

Antibiotic impregnated catheters and intrathecal antibiotics for CSF shunt infection prevention in children undergoing low-risk CSF shunt surgery.

Podkovik S, Zhou C, Coffin S, Hall M, Hauptman J, Kronman M BMC Pediatr. 2024; 24(1):325.

PMID: 38734598 PMC: 11088062. DOI: 10.1186/s12887-024-04798-9.

Utilization trends in cerebrospinal fluid shunt infection prevention techniques in the United States from 2007 to 2015.

Podkovik S, Zhou C, Coffin S, Hall M, Hauptman J, Kronman M J Neurosurg Pediatr. 2024; 33(4):349-358.

PMID: 38181501 PMC: 10810681. DOI: 10.3171/2023.11.PEDS2337.

Ventriculoperitoneal Shunt Surgery in Brunei Darussalam: A Population-Based Perspective.

Boban M, Mathew J, Thien A Asian J Neurosurg. 2023; 18(3):597-601.

PMID: 38152520 PMC: 10749857. DOI: 10.1055/s-0043-1774395.

Associations of Standard Care, Intrathecal Antibiotics, and Antibiotic-Impregnated Catheters With Cerebrospinal Fluid Shunt Infection Organisms and Resistance.

Sedano S, Kronman M, Whitlock K, Zhou C, Coffin S, Hauptman J J Pediatric Infect Dis Soc. 2023; 12(9):504-512.

PMID: 37681670 PMC: 10848219. DOI: 10.1093/jpids/piad064.

References

Walters B, Hoffman H, HENDRICK E, Humphreys R . Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg. 1984; 60(5):1014-21. DOI: 10.3171/jns.1984.60.5.1014. View

Bayston R, Grove N, Siegel J, Lawellin D, Barsham S . Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry. 1989; 52(5):605-9. PMC: 1032173. DOI: 10.1136/jnnp.52.5.605. View

Sciubba D, McGirt M, Woodworth G, Carson B, Jallo G . Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst. 2007; 23(8):867-71. DOI: 10.1007/s00381-007-0334-5. View

Kan P, Kestle J . Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst. 2007; 23(7):773-7. DOI: 10.1007/s00381-007-0296-7. View

Shapiro S, Boaz J, Kleiman M, Kalsbeck J, Mealey J . Origin of organisms infecting ventricular shunts. Neurosurgery. 1988; 22(5):868-72. View

Fan-Havard P, Nahata M . Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm. 1987; 6(11):866-80. View

Bayston R, Lambert E . Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg. 1997; 87(2):247-51. DOI: 10.3171/jns.1997.87.2.0247. View

Aryan H, Meltzer H, Park M, Bennett R, Jandial R, Levy M . Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst. 2004; 21(1):56-61. DOI: 10.1007/s00381-004-1052-x. View

Kulkarni A, Drake J . Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg. 2001; 94(2):195-201. DOI: 10.3171/jns.2001.94.2.0195. View

10.

Bayston R, Ashraf W, Bhundia C . Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother. 2004; 53(5):778-82. DOI: 10.1093/jac/dkh183. View

11.

Vanaclocha V, Saiz-Sapena N, Leiva J . Shunt malfunction in relation to shunt infection. Acta Neurochir (Wien). 1996; 138(7):829-34. DOI: 10.1007/BF01411261. View

12.

Govender S, Nathoo N, van Dellen J . Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg. 2003; 99(5):831-9. DOI: 10.3171/jns.2003.99.5.0831. View

13.

Sciubba D, Stuart R, McGirt M, Woodworth G, Samdani A, Carson B . Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg. 2005; 103(2 Suppl):131-6. DOI: 10.3171/ped.2005.103.2.0131. View

14.

Pople I, Bayston R, Hayward R . Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg. 1992; 77(1):29-36. DOI: 10.3171/jns.1992.77.1.0029. View

15.

Borgbjerg B, Gjerris F, Albeck M, Borgesen S . Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien). 1995; 136(1-2):1-7. DOI: 10.1007/BF01411427. View

16.

Choux M, Genitori L, Lang D, Lena G . Shunt implantation: reducing the incidence of shunt infection. J Neurosurg. 1992; 77(6):875-80. DOI: 10.3171/jns.1992.77.6.0875. View

17.

Ronan A, Hogg G, Klug G . Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J. 1995; 14(9):782-6. DOI: 10.1097/00006454-199509000-00010. View

18.

Schiff S, Oakes W . Delayed cerebrospinal-fluid shunt infection in children. Pediatr Neurosci. 1989; 15(3):131-5. DOI: 10.1159/000120458. View

19.

Zabramski J, Whiting D, Darouiche R, Horner T, Olson J, Robertson C . Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003; 98(4):725-30. DOI: 10.3171/jns.2003.98.4.0725. View

20.

Wang K, Chang W, Shih T, Huang C, Tsai N, Chang C . Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes. Jpn J Infect Dis. 2004; 57(2):44-8. View